Hugel, Inc. (KOSDAQ:145020)
313,500
+500 (0.16%)
Sep 19, 2025, 3:30 PM KST
Hugel Market Cap
Hugel has a market cap or net worth of 3.38 trillion as of September 19, 2025. Its market cap has increased by 9.39% in one year.
Market Cap
3.38T
Enterprise Value
2.96T
Revenue
403.40B
Ranking
n/a
PE Ratio
24.19
Stock Price
313,500.00
Market Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 3.38T, an increase of 512.43%. That is a compound annual growth rate of 20.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 3,384.89B | 9.58% |
Dec 30, 2024 | 3,089.09B | 84.38% |
Dec 28, 2023 | 1,675.39B | 4.84% |
Dec 29, 2022 | 1,597.99B | -14.29% |
Dec 30, 2021 | 1,864.45B | -20.74% |
Dec 30, 2020 | 2,352.30B | 75.24% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Dec 24, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.24T |
Celltrion | 37.12T |
ALTEOGEN | 25.30T |
Yuhan | 8,752.85B |
SK Biopharmaceuticals | 8,450.00B |
Peptron | 6,744.58B |
PharmaResearch | 6,316.91B |
ABL Bio | 5,473.88B |